1. Home
  2. TCRX vs INTG Comparison

TCRX vs INTG Comparison

Compare TCRX & INTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TScan Therapeutics Inc.

TCRX

TScan Therapeutics Inc.

HOLD

Current Price

$1.11

Market Cap

75.1M

Sector

Health Care

ML Signal

HOLD

Logo Intergroup Corporation (The)

INTG

Intergroup Corporation (The)

HOLD

Current Price

$39.10

Market Cap

71.6M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
TCRX
INTG
Founded
2018
1965
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Building operators
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
75.1M
71.6M
IPO Year
2021
1995

Fundamental Metrics

Financial Performance
Metric
TCRX
INTG
Price
$1.11
$39.10
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$7.00
N/A
AVG Volume (30 Days)
937.1K
12.3K
Earning Date
05-08-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
12.28
N/A
EPS
N/A
0.67
Revenue
$10,325,000.00
$74,753,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$19.81
N/A
P/E Ratio
N/A
$58.21
Revenue Growth
266.65
4.43
52 Week Low
$0.88
$10.37
52 Week High
$2.57
$43.84

Technical Indicators

Market Signals
Indicator
TCRX
INTG
Relative Strength Index (RSI) 44.12 53.99
Support Level $0.93 $29.93
Resistance Level $1.21 $42.44
Average True Range (ATR) 0.10 2.43
MACD -0.02 -0.15
Stochastic Oscillator 5.27 36.38

Price Performance

Historical Comparison
TCRX
INTG

About TCRX TScan Therapeutics Inc.

TScan Therapeutics Inc is a fully integrated clinical-stage biotechnology company focused on developing a robust pipeline of T cell receptor (TCR)-engineered T cell, or TCR-T, therapies for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.

About INTG Intergroup Corporation (The)

The Intergroup Corp is a company operating in the real estate sector. It was formed to buy, develop, operate, rehabilitate, and dispose of real property of various types and descriptions, as well as to engage in other related business and investment activities. The company operates through three segments: Hotel, Real Estate, and Investment Transactions. The Hotel Operations segment, which generates the majority of the revenue, covers the operation of the Hilton hotel and garage. The Real Estate Operations segment involves the management of multifamily rental properties, while the Investment Transactions segment includes investments of cash in marketable securities and other assets.

Share on Social Networks: